First case of rare blood-clotting condition linked to J&J COVID-19 vaccine diagnosed in Utah –

SALT LAKE CITY– The first case of an uncommon blood-clotting condition believed to be linked to the Johnson & & Johnson COVID-19 vaccine has been detected in Utah.A male client was just recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, likewise referred to as VITT, at the University of Utah Hospital, U. health authorities said in a Wednesday news release.The patient was dealt with and is now recuperating in your home, according to the release. Health authorities didnt provide anymore detail about the case in the release. A press conference is arranged for 2:30 p.m. Wednesday where doctors are expected to more go over the case.The embolism condition resulted in an across the country pause on administration of the Johnson & & Johnson vaccine last month after 6 cases were reported amongst over 6 million individuals who received the vaccine. The time out was lifted on April 23 after federal regulators figured out the vaccines continued use was safe.This story will be updated. × More stories you may be interested in

Leave a Reply

Your email address will not be published. Required fields are marked *